Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02489448
Recruitment Status : Recruiting
First Posted : July 3, 2015
Last Update Posted : June 13, 2019
Sponsor:
Information provided by (Responsible Party):
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 2019
  Estimated Study Completion Date : October 2019